Skip to main content
Clinical Trials/NCT03187002
NCT03187002CompletedNot Applicable

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion: A Blinded Randomized Controlled Trial

Stanford University1 site in 1 country109 target enrollmentStarted: January 18, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
109
Locations
1
Primary Endpoint
Aspiration Pain

Study Overview

Brief Summary

High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Transcutaneous electrical nerve stimulation (TENS)

Experimental

Transcutaneous electrical nerve stimulation (TENS)

Intervention: Transcutaneous electrical nerve stimulation (TENS) (Device)

Moderate IV Sedation

Active Comparator

Fentanyl, versed

Intervention: Moderate IV Sedation (Drug)

Outcomes

Primary Outcomes

Aspiration Pain

Time Frame: Intraoperative, collected during procedure at the time of aspiration (up to 30 seconds)

Pain with aspiration, assessed by visual analogue scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable")

Secondary Outcomes

  • Paracervical Block Pain(Intraoperative, collected during procedure (up to 30 seconds))
  • Speculum Placement Pain(Intraoperative, collected during procedure (up to 30 seconds))
  • Manual Cervical Dilation Pain(Intraoperative, collected during procedure (up to 30 seconds))
  • Tenaculum Placement Pain(Intraoperative, collected during procedure (up to 30 seconds))
  • Speculum Removal Pain(Intraoperative, collected during procedure (up to 30 seconds))
  • Total Procedure Time(Intraoperative, collected during procedure (up to 20 minutes))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials